{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:42:13Z","timestamp":1784590933149,"version":"3.55.0"},"reference-count":30,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,10,9]],"date-time":"2008-10-09T00:00:00Z","timestamp":1223510400000},"content-version":"vor","delay-in-days":3903,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[1998,2]]},"abstract":"<jats:sec><jats:label\/><jats:p>Sj\u00f6berg K, Eriksson KF, Bredberg A, Wassmuth R, Eriksson S (University of Lund, University Hospital, Malm\u00f6, Sweden; and University of Erlangen\u2010N\u00fcrnberg, Erlangen, Germany). Screening for coeliac disease in adult insulin\u2010dependent diabetes mellitus. <jats:italic>J Intern Med<\/jats:italic> 1998; <jats:bold>243<\/jats:bold>: 133\u201340.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To study, by sequential screening for gliadin antibodies (GA) and endomysial antibodies (EMA), the prevalence and clinical characteristics of coeliac disease (CD) in adult IDDM patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Subjects and measurements<\/jats:title><jats:p>A series comprising 1664 diabetes patients [848 with IDDM, 745 with non\u2010insulin\u2010dependent diabetes (NIDDM) and 71 with secondary diabetes] were screened for GA. IgA\u2010 or IgG\u2010GA positive sera were analysed for EMA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>IgA\u2010GA were more frequent in all the diabetes subgroups (13.7% in IDDM,12.3% in NIDDM and 23.9% in secondary diabetes, <jats:italic>P<\/jats:italic> &lt; 0.001 in all three cases) than among healthy blood donors (4.7%). Two patients with NIDDM had CD. Of the IDDM group (<jats:italic>n<\/jats:italic>= 848), 8 had previously diagnosed CD and 14 more (of whom 7 could be biopsied) were EMA positive. All had villous atrophy. The minimum prevalence of CD (including probable cases) in IDDM was 2.6% (22\/848). Patients with previously known CD had more symptoms (<jats:italic>P<\/jats:italic> &lt; 0.001), more deficiency states (<jats:italic>P<\/jats:italic> &lt; 0.001) and more autoimmune diseases (<jats:italic>P<\/jats:italic> &lt; 0.04) than those identified by screening. IDDM patients with a diabetes duration of 31\u201040 years were characterised by a higher prevalence of CD than patients with a duration of less than 30 years (6.7% vs. 1.7%; <jats:italic>P<\/jats:italic> &lt; 0.02).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Serial analysis of GA and EMA confirmed a high prevalence of CD in adult IDDM (2.6%). False\u2010positive IgA\u2010GA test results are frequent in patients with diabetes, irrespective of type. EMA analysis is the preferable screening tool for CD in diabetes.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2796.1998.00256.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:06:44Z","timestamp":1047449204000},"page":"133-140","source":"Crossref","is-referenced-by-count":54,"title":["Screening for coeliac disease in adult insulin\u2010dependent diabetes mellitus"],"prefix":"10.1111","volume":"243","author":[{"family":"SJ\u00d6berg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Bredberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Wassmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,10,9]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.50.579.45"},{"key":"e_1_2_6_3_2","first-page":"151","article-title":"Autoantibodies and autoimmune diseases in young diabetics.","volume":"13","author":"Kontiainen S","year":"1990","journal-title":"Diabetes Research"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.8.1.S10"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.59.8.739"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(86)81042-3"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.66.4.491"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00445915"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909092243"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02087768"},{"key":"e_1_2_6_11_2","first-page":"631","article-title":"The prevalence of coeliac disease in adult diabetes mellitus.","volume":"87","author":"Page SR","year":"1994","journal-title":"QJM"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1993.tb12551.x"},{"key":"e_1_2_6_13_2","first-page":"66","article-title":"High prevalence of coeliac disease in healthy adults revealed by antigliadin antibodies.","volume":"69","author":"Grodzinsky E","year":"1991","journal-title":"Ann Allergy"},{"key":"e_1_2_6_14_2","article-title":"The prevalence of adult coeliac disease in Finland.","volume":"30","author":"Collin P","year":"1995","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90989-X"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409090472"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-199105000-00001"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409096837"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409092489"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1994.tb00124.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.16.6.902"},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2337\/diab.35.2.237","article-title":"Islet cell antibodies identify latent type I diabetes in patients aged 35\u201375 years at diagnosis.","volume":"35","author":"Groop L","year":"1986","journal-title":"Diabetes"},{"key":"e_1_2_6_23_1","unstructured":"WHO Study Group. Report of diabetes mellitus technical report series no 727. World Health Organisation Geneva 1985."},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.6.771"},{"key":"e_1_2_6_25_2","unstructured":"Immunopathology of the skin. New York: Dowden Hutchinson and Ross Inc 1973; 225."},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1984.tb06601.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91819-P"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.1955.tb01348.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00404139"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.36.2.239"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609031627"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2796.1998.00256.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2796.1998.00256.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1365-2796.1998.00256.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2796.1998.00256.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T02:38:59Z","timestamp":1694399939000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2796.1998.00256.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["10.1046\/j.1365-2796.1998.00256.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2796.1998.00256.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,2]]}}}